Release Date: December 23, 2025
Expiration Date: December 23, 2026
Activity Overview
This educational activity is an archive of the live presentation held on Wednesday, December 10, 2025.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward medical oncologists, advanced practice providers, nurses, and other health care professionals involved in the treatment and management of triple-negative breast cancer (TNBC).
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Apply actionable biomarkers alongside tumor and patient-specific factors to guide treatment decisions in early and advanced triple-negative breast cancer (TNBC)
- Develop personalized treatment strategies informed by current and emerging trial evidence for early and advanced TNBC
- Implement approaches to proactively mitigate, monitor, and manage treatment-related adverse events
- Evaluate ongoing clinical trials in early and advanced TNBC investigating novel agents and combination strategies
Hope S. Rugo, MD
Director, Women’s Cancers Program
Division Chief, Breast Medical Oncology
Professor, Department of Medical Oncology & Therapeutics
Research
City of Hope Comprehensive Cancer Center
Duarte, CA
Professor Emeritus, UCSF
San Francisco, CA
Alison K. Conlin, MD
Medical Oncologist
Providence Cancer Institute
Portland, OR
Marleen Kok, MD, PhD
Group Leader, Breast Cancer Immunotherapy Group
The Netherlands Cancer Institute
Amsterdam, The Netherlands
Heather McArthur, MD, MPH
Professor of Internal Medicine
Clinical Director, Breast Cancer Program
Komen Distinguished Chair in Clinical Breast Cancer Researc
UT Southwestern Medical Center
Dallas, TX
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC (PER®) have no relevant financial relationships with ineligible companies.
PER mitigated all COI for faculty, staff, and planners prior to the start of this activity.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any company that provided commercial support for this activity.